牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

海特生物（300683）

4.7

综合诊断：4.7分打败了18%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
正处于反弹阶段。
长期趋势：
已有19家主力机构披露2025-06-30报告期持股数据，持仓量总计4429.32万股，占流通A股36.29%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

7.8分

3.0分

3.9分

1.9分

4.0分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：7.8技术面打败了76%的股票技术面评分前10的股票

近期的平均成本为29.62元。空头行情中，目前正处于反弹阶段，投资者可适当关注。

技术面得分最高的股票

平均成本

近期的平均成本为29.62元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"29.62","date":1770019448,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。

[{"date":"2026.02.03","stock":"5.13","trade":"2.98","ind":"2.19"},{"date":"2026.02.02","stock":"-5.41","trade":"-2.41","ind":"-2.69"},{"date":"2026.01.30","stock":"-1.11","trade":"-0.83","ind":"-0.66"},{"date":"2026.01.29","stock":"-2.11","trade":"0.02","ind":"-0.30"},{"date":"2026.01.28","stock":"-3.60","trade":"-2.58","ind":"0.09"},{"date":"2026.01.27","stock":"-0.61","trade":"-0.65","ind":"0.09"},{"date":"2026.01.26","stock":"-1.89","trade":"-1.24","ind":"-0.85"},{"date":"2026.01.23","stock":"7.66","trade":"1.99","ind":"0.79"},{"date":"2026.01.22","stock":"4.28","trade":"0.27","ind":"0.50"},{"date":"2026.01.21","stock":"5.74","trade":"0.89","ind":"0.70"},{"date":"2026.01.20","stock":"-1.85","trade":"-0.87","ind":"-0.97"},{"date":"2026.01.19","stock":"-2.79","trade":"-0.91","ind":"0.09"},{"date":"2026.01.16","stock":"-4.70","trade":"-2.90","ind":"-0.18"},{"date":"2026.01.15","stock":"-4.96","trade":"-2.92","ind":"0.41"},{"date":"2026.01.14","stock":"4.98","trade":"2.04","ind":"0.56"},{"date":"2026.01.13","stock":"3.65","trade":"4.44","ind":"-1.37"},{"date":"2026.01.12","stock":"-0.90","trade":"3.34","ind":"1.75"},{"date":"2026.01.09","stock":"2.10","trade":"3.44","ind":"1.15"},{"date":"2026.01.08","stock":"0.99","trade":"1.92","ind":"-0.51"},{"date":"2026.01.07","stock":"-0.75","trade":"1.38","ind":"0.06"},{"date":"2026.01.06","stock":"0.96","trade":"1.06","ind":"1.40"}]

海特生物,深证成指,医疗服务指数

压力支撑

该股压力位为29.27元，支撑位为28.43元。

[{"text":"\u538b\u529b\u4f4d","value":"29.27","date":1770048000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"28.43","date":1770048000,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.0资金面打败了26%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：02月03日 20:30

机构今日流向(万元)	2422.30	机构5日流向(万元)	-5954.60
机构10日流向(万元)	-16036.25	机构20日流向(万元)	-38607.82

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量减少209.65万股，其中基金净减仓4家，主力净减仓15家，请投资者中长期谨慎为宜。

截止2025-06-30，共19家主力机构（基金15家，一般法人4家），持仓量总计4429.32万股，占流通A股36.29%
其中，基金持仓与2024-12-31相比：
增仓：1家，增持 0.31万股
减仓：5家，减持 3.61万股
新出现在主力名单中：9家，持有19.79万股
从主力名单中消失：24家，原持有226.14万股

消息面诊股

诊断结果：3.9消息面打败了12%的股票今日有利好新闻的公司

近期利空消息较多且有重大利空，消息面发出消极信号。

消息面得分最高的股票

消息列表

重大利空	业绩预告	预计增亏	2026-01-23
一般消息	股东大会	临时股东大会	2026-01-21
一般消息	高管变动	取消监事会	2025-11-07
一般消息	分红转增	不分配不转增	2025-08-26
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-06-30
一般消息	分红转增	不分配不转增	2025-04-21
一般消息	重大事项	公司股东股份解押	2025-03-27

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	1条	1条	0条

行业面诊股

诊断结果：1.9行业面打败了21%的股票医疗服务行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2026.02.03","price":"2.19","value":"2.98"},{"date":"2026.02.02","price":"-2.69","value":"-2.41"},{"date":"2026.01.30","price":"-0.66","value":"-0.83"},{"date":"2026.01.29","price":"-0.30","value":"0.02"},{"date":"2026.01.28","price":"0.09","value":"-2.58"},{"date":"2026.01.27","price":"0.09","value":"-0.65"},{"date":"2026.01.26","price":"-0.85","value":"-1.24"},{"date":"2026.01.23","price":"0.79","value":"1.99"},{"date":"2026.01.22","price":"0.50","value":"0.27"},{"date":"2026.01.21","price":"0.70","value":"0.89"},{"date":"2026.01.20","price":"-0.97","value":"-0.87"},{"date":"2026.01.19","price":"0.09","value":"-0.91"},{"date":"2026.01.16","price":"-0.18","value":"-2.90"},{"date":"2026.01.15","price":"0.41","value":"-2.92"},{"date":"2026.01.14","price":"0.56","value":"2.04"},{"date":"2026.01.13","price":"-1.37","value":"4.44"},{"date":"2026.01.12","price":"1.75","value":"3.34"},{"date":"2026.01.09","price":"1.15","value":"3.44"},{"date":"2026.01.08","price":"-0.51","value":"1.92"},{"date":"2026.01.07","price":"0.06","value":"1.38"},{"date":"2026.01.06","price":"1.40","value":"1.06"}]

深证成指,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	泓博医药	53.26%	-0.37%	6.8分
2	迪安诊断	40.75%	-4.77%	5.3分
3	华康洁净	33.67%	5.96%	6.8分
4	益诺思	32.50%	-4.20%	5.2分
5	美年健康	31.02%	-0.14%	5.3分
6	百奥赛图	30.73%	1.10%	7.4分
7	普蕊斯	30.28%	5.46%	6.5分
8	诺思格	28.30%	12.43%	6.0分
9	成都先导	16.99%	-4.66%	5.8分
10	通策医疗	16.88%	4.62%	6.7分
11	诺禾致源	13.16%	-2.81%	6.5分
12	创新医疗	10.64%	-0.07%	5.7分
13	万邦医药	9.94%	-0.51%	5.3分
14	光正眼科	9.72%	-16.73%	6.1分
15	兰卫医学	9.64%	-4.33%	5.5分
16	ST中珠	8.73%	-1.79%	5.2分
17	新里程	8.64%	-2.05%	5.0分
18	南模生物	8.16%	-1.85%	6.5分
19	睿智医药	7.97%	-1.72%	6.1分
20	泰格医药	7.15%	8.03%	7.3分
21	何氏眼科	5.53%	-1.76%	5.5分
22	药康生物	5.35%	-5.56%	5.6分
23	普瑞眼科	5.27%	-1.79%	6.7分
24	华大基因	5.03%	-5.18%	4.8分
25	金域医学	4.98%	-3.46%	5.8分
26	金凯生科	4.90%	-3.99%	5.7分
27	澳洋健康	4.59%	-1.59%	5.7分
28	博济医药	3.63%	-1.95%	4.6分
29	药石科技	3.16%	-2.33%	4.5分
30	-	3.05%	-7.82%	分
31	凯莱英	2.47%	-0.98%	5.3分
32	海特生物	2.45%	-7.20%	4.7分
33	贝瑞基因	1.92%	-5.93%	4.6分
34	盈康生命	1.69%	-3.05%	5.2分
35	美迪西	0.95%	2.48%	5.8分
36	和元生物	0.71%	-7.10%	5.2分
37	华厦眼科	0.00%	-2.79%	5.6分
38	*ST生物	-0.11%	-1.02%	5.0分
39	药明康德	-1.71%	-1.24%	6.1分
40	昭衍新药	-1.74%	-2.23%	4.8分
41	阳光诺和	-2.45%	-5.02%	5.4分
42	爱尔眼科	-2.47%	-0.72%	5.4分
43	博腾股份	-2.70%	-7.07%	4.7分
44	康龙化成	-2.95%	-2.50%	5.2分
45	九洲药业	-3.98%	-4.54%	5.1分
46	奥浦迈	-4.20%	-9.82%	5.6分
47	皓宸医疗	-4.79%	-5.40%	4.4分
48	国际医学	-4.82%	-2.56%	4.6分
49	皓元医药	-6.44%	-16.57%	5.4分
50	毕得医药	-7.01%	-11.91%	5.2分
51	三博脑科	-7.36%	1.64%	4.8分
52	百诚医药	-12.44%	-7.82%	3.2分
53	诚达药业	-14.54%	-7.26%	4.3分
54	百花医药	-25.33%	-4.89%	4.8分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.0基本面打败了1%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，暂时未获得多数机构的显著认同，长期投资价值一般。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 50/102 ， 23/102。

[{"date":"2025-09-30","value":"-6.84","vol":"3.33"},{"date":"2025-06-30","value":"-1.65","vol":"2.29"},{"date":"2025-03-31","value":"-0.58","vol":"0.92"},{"date":"2024-12-31","value":"-2.85","vol":"-0.06"},{"date":"2024-09-30","value":"-1.62","vol":"3.18"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	-6.84	-1.65	-0.58	-2.85	-1.62
行业(%)	3.33	2.29	0.92	-0.06	3.18

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"41.81","vol":"36.63"},{"date":"2025-06-30","value":"40.74","vol":"36.78"},{"date":"2025-03-31","value":"44.38","vol":"34.67"},{"date":"2024-12-31","value":"42.85","vol":"35.58"},{"date":"2024-09-30","value":"45.24","vol":"36.89"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	41.81	40.74	44.38	42.85	45.24
行业(%)	36.63	36.78	34.67	35.58	36.89

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 39/102 ， 52/102。

[{"date":"2025-09-30","value":"-6.45","vol":"3.55"},{"date":"2025-06-30","value":"-3.36","vol":"3.34"},{"date":"2025-03-31","value":"18.79","vol":"-0.08"},{"date":"2024-12-31","value":"7.75","vol":"-0.03"},{"date":"2024-09-30","value":"2.87","vol":"0.85"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-6.45	-3.36	18.79	7.75	2.87
行业(%)	3.55	3.34	-0.08	-0.03	0.85

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-297.78","vol":"19.50"},{"date":"2025-06-30","value":"-72.10","vol":"-66.44"},{"date":"2025-03-31","value":"15.81","vol":"-25.93"},{"date":"2024-12-31","value":"42.60","vol":"-92.66"},{"date":"2024-09-30","value":"-50.32","vol":"-158.04"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-297.78	-72.10	15.81	42.60	-50.32
行业(%)	19.50	-66.44	-25.93	-92.66	-158.04

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 46/102 ， 33/102。

[{"date":"2025-09-30","value":"0.15","vol":"0.31"},{"date":"2025-06-30","value":"0.10","vol":"0.20"},{"date":"2025-03-31","value":"0.05","vol":"0.10"},{"date":"2024-12-31","value":"0.22","vol":"0.41"},{"date":"2024-09-30","value":"0.15","vol":"0.31"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.15	0.10	0.05	0.22	0.15
行业(次)	0.31	0.20	0.10	0.41	0.31

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"2.53","vol":"11.19"},{"date":"2025-06-30","value":"1.57","vol":"7.29"},{"date":"2025-03-31","value":"0.80","vol":"3.76"},{"date":"2024-12-31","value":"3.28","vol":"16.08"},{"date":"2024-09-30","value":"2.08","vol":"13.98"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	2.53	1.57	0.80	3.28	2.08
行业(次)	11.19	7.29	3.76	16.08	13.98

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"-12.24","vol":"16.25"},{"date":"2025-06-30","value":"-6.99","vol":"15.87"},{"date":"2025-03-31","value":"-31.78","vol":"-1.69"},{"date":"2024-12-31","value":"-2.55","vol":"22.45"},{"date":"2024-09-30","value":"-1.50","vol":"12.75"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	-12.24	-6.99	-31.78	-2.55	-1.50
行业	16.25	15.87	-1.69	22.45	12.75

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.63","vol":"0.93"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.45","vol":"1.29"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.63	-	0.45	-
行业	0.01	0.93	0.00	1.29	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 43/102 ， 43/102。

[{"date":"2025-09-30","value":"4.60","vol":"3.76"},{"date":"2025-06-30","value":"4.89","vol":"3.66"},{"date":"2025-03-31","value":"4.76","vol":"3.84"},{"date":"2024-12-31","value":"3.60","vol":"3.66"},{"date":"2024-09-30","value":"4.03","vol":"4.04"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	4.60	4.89	4.76	3.60	4.03
行业	3.76	3.66	3.84	3.66	4.04

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"4.11","vol":"3.03"},{"date":"2025-06-30","value":"4.35","vol":"2.95"},{"date":"2025-03-31","value":"4.21","vol":"3.12"},{"date":"2024-12-31","value":"3.24","vol":"2.98"},{"date":"2024-09-30","value":"3.56","vol":"3.32"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	4.11	4.35	4.21	3.24	3.56
行业	3.03	2.95	3.12	2.98	3.32

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 42/102 ， 45/102。

[{"date":"2025-09-30","value":"14.91","vol":"32.25"},{"date":"2025-06-30","value":"14.71","vol":"33.24"},{"date":"2025-03-31","value":"15.03","vol":"32.24"},{"date":"2024-12-31","value":"17.88","vol":"32.93"},{"date":"2024-09-30","value":"16.65","vol":"30.45"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	14.91	14.71	15.03	17.88	16.65
行业(%)	32.25	33.24	32.24	32.93	30.45

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.18","vol":"0.92"},{"date":"2025-06-30","value":"0.17","vol":"0.96"},{"date":"2025-03-31","value":"0.18","vol":"0.98"},{"date":"2024-12-31","value":"0.22","vol":"1.03"},{"date":"2024-09-30","value":"0.20","vol":"0.83"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.18	0.17	0.18	0.22	0.20
行业(%)	0.92	0.96	0.98	1.03	0.83

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"0.28","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-0.14","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-1.21","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.69","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[海特生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]